Medscinet AB

Medscinet AB is an SME in Stockholm, Sweden that has taken part in 2 EU-funded projects since 2012, receiving €253k in EU funding.

EU funding received€253k
EU projects2
As coordinator0
Running now0
First EU project2012
Latest project2016
CountrySweden
EU registration (PIC)954444305
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Medscinet AB's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€132k · 1 project
  • Horizon 2020€121k · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • BOOSTB4Partner

    Boost Brittle Bones Before Birth

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

    €121ktheir share
  • IMPROvEDPartner

    IMPROvED: IMproved Pregnancy Outcomes by Early Detection; personalized medicine for pregnant women: novel metabolomic and proteomic biomarkers to detect pre-eclampsia and improve outcome

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €132ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • fetal medicine
  • immunology
  • mass spectrometry
  • muscular dystrophies
  • obstetrics
  • personalized medicine
  • proteomics
  • stem cells
  • transplantation

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime